Israel - hebraisk - Ministry of Health

trima israel pharmaceutical products maabarot ltd - pramipexole dihydrochloride monohydrate 0.25 mg - tablets - pramipexole - treatment of signs and symptoms of idiopathic parkinson's disease, as monotherapy or in combination with levodopa. for symptomatic treatment of moderate to severe idiopathic restless legs syndrome.

Israel - hebraisk - Ministry of Health

trima israel pharmaceutical products maabarot ltd - pramipexole dihydrochloride monohydrate 1 mg - tablets - pramipexole - treatment of signs and symptoms of idiopathic parkinson's disease, as monotherapy or in combination with lovodopa.

Israel - hebraisk - Ministry of Health

salomon,levin & elstein ltd - pramipexole dihydrochloride monohydrate 0.25 mg - tablets - pramipexole - treatment of the signs and symptoms of idiopathic parkinson's disease, it may be used as monotherapy or in combination with levodopa, as well as symptomatic treatment of moderate to severe idiopathic restless legs syndrome.

Israel - hebraisk - Ministry of Health

salomon,levin & elstein ltd - pramipexole dihydrochloride monohydrate 1 mg - tablets - pramipexole - treatment of the signs and symptoms of idiopathic parkinson's disease, it may be used as monotherapy or in combination with levodopa.

Israel - hebraisk - Ministry of Health

rafa laboratories ltd - pramipexole dihydrochloride monohydrate 4.5 mg - tablets extended release - pramipexole - treatment of signs and symptoms of idiopathic parkinson’s disease, as monotherapy or in combination with lovodopa.

Israel - hebraisk - Ministry of Health

boehringer ingelheim israel ltd. - pramipexole dihydrochloride monohydrate - טבליות עם שחרור נרחב - pramipexole dihydrochloride monohydrate 4.5 mg - pramipexole - pramipexole - treatment of signs and symptoms of idiopathic parkinson’s disease, as monotherapy or in combination with lovodopa.

Israel - hebraisk - Ministry of Health

pfizer pfe pharmaceuticals israel ltd - cabergoline - טבליה - cabergoline 0.5 mg - cabergoline - cabergoline - treatment of hyperprolactinemic disorders.dostinex is indicated for the treatment of dysfunctions associated with hyperprolactinemia, including amenorrhea, oligomenorrhea, anovulation and galactorrhea. dostinex is indicated in patients with prolactin-secreting pituitary adenomas (micro-and macroprolactinomas), idiopathic hyperprolactinemia, or empty sella syndrome with associated hyperprolactinemia. inhibition and supression of lactation .

Israel - hebraisk - Ministry of Health

pfizer pharmaceuticals israel ltd - cabergoline 1 mg - tablets - cabergoline - parkinson's disease. combination therapy with l-dopa and as monotherapy for newly diagnosed illness.

Israel - hebraisk - Ministry of Health

pfizer pharmaceuticals israel ltd - cabergoline 2 mg - tablets - cabergoline - parkinson's disease. combination therapy with l-dopa and as monotherapy for newly diagnosed illness.

Israel - hebraisk - Ministry of Health

trima israel pharmaceutical products maabarot ltd - cabergoline - טבליה - cabergoline 2 mg - cabergoline - cabergoline - parkinson's disease. combination therapy with l-dopa and as monotherapy for newly diagnosed illness.